Tempus AI (NASDAQ:TEM) Downgraded by William Blair to “Market Perform”

Tempus AI (NASDAQ:TEM) was downgraded by research analysts at William Blair from an “outperform” rating to a “market perform” rating in a research report issued on Wednesday, Marketbeat.com reports.

Other research analysts also recently issued reports about the company. Bank of America upped their target price on Tempus AI from $52.00 to $54.00 and gave the stock a “neutral” rating in a research note on Friday, December 13th. Piper Sandler restated a “neutral” rating and set a $70.00 price objective (up from $40.00) on shares of Tempus AI in a research report on Tuesday, November 12th. Loop Capital dropped their target price on shares of Tempus AI from $57.00 to $52.00 and set a “buy” rating on the stock in a research report on Tuesday, January 14th. Needham & Company LLC reissued a “buy” rating and set a $56.00 target price on shares of Tempus AI in a research note on Tuesday, January 14th. Finally, TD Cowen reaffirmed a “buy” rating and issued a $74.00 price target (up from $58.00) on shares of Tempus AI in a research note on Wednesday, February 5th. Four analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. According to MarketBeat.com, Tempus AI has an average rating of “Moderate Buy” and an average target price of $58.55.

Tempus AI Stock Performance

Shares of Tempus AI stock opened at $83.75 on Wednesday. The business has a 50-day moving average price of $45.82 and a 200 day moving average price of $49.97. The company has a debt-to-equity ratio of 8.17, a quick ratio of 2.55 and a current ratio of 2.69. Tempus AI has a twelve month low of $22.89 and a twelve month high of $86.00.

Insider Buying and Selling at Tempus AI

In other news, EVP Erik Phelps sold 5,934 shares of the business’s stock in a transaction dated Wednesday, February 5th. The shares were sold at an average price of $67.57, for a total transaction of $400,960.38. Following the transaction, the executive vice president now owns 214,662 shares of the company’s stock, valued at approximately $14,504,711.34. The trade was a 2.69 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Eric P. Lefkofsky sold 476,209 shares of the firm’s stock in a transaction dated Wednesday, January 22nd. The stock was sold at an average price of $49.84, for a total transaction of $23,734,256.56. Following the sale, the chief executive officer now owns 6,502,643 shares of the company’s stock, valued at approximately $324,091,727.12. The trade was a 6.82 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 2,229,449 shares of company stock worth $102,293,124.

Hedge Funds Weigh In On Tempus AI

Several institutional investors and hedge funds have recently bought and sold shares of the company. ARK Investment Management LLC increased its holdings in shares of Tempus AI by 132.1% during the 4th quarter. ARK Investment Management LLC now owns 5,519,644 shares of the company’s stock worth $186,343,000 after buying an additional 3,141,487 shares during the last quarter. NEA Management Company LLC grew its position in Tempus AI by 17.8% in the third quarter. NEA Management Company LLC now owns 5,385,979 shares of the company’s stock worth $304,846,000 after acquiring an additional 813,169 shares during the period. Sumitomo Mitsui Trust Group Inc. increased its stake in Tempus AI by 166.0% during the fourth quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,239,093 shares of the company’s stock worth $109,352,000 after acquiring an additional 2,021,394 shares during the last quarter. Nikko Asset Management Americas Inc. increased its stake in Tempus AI by 166.0% during the fourth quarter. Nikko Asset Management Americas Inc. now owns 3,239,093 shares of the company’s stock worth $109,352,000 after acquiring an additional 2,021,394 shares during the last quarter. Finally, Franklin Resources Inc. raised its position in Tempus AI by 240.5% in the fourth quarter. Franklin Resources Inc. now owns 2,762,173 shares of the company’s stock valued at $93,251,000 after purchasing an additional 1,950,862 shares during the period. 24.22% of the stock is currently owned by institutional investors and hedge funds.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.